{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:51:50Z","timestamp":1785901910944,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M782053"],"award-info":[{"award-number":["2025M782053"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272856"],"award-info":[{"award-number":["82272856"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573217"],"award-info":[{"award-number":["82573217"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drup.2026.101438","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:44:17Z","timestamp":1782492257000},"page":"101438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability"],"prefix":"10.1016","volume":"88","author":[{"given":"Shengdong","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaze","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyue","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-han","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Lu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-8077","authenticated-orcid":false,"given":"Shan-Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101438_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2026.101438_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s43018-025-00952-z","article-title":"CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors","volume":"6","author":"Chen","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2026.101438_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202501284","article-title":"A super-enhancer-driven transcriptional regulatory circuit underlying abiraterone resistance in castration-resistant prostate cancer","volume":"12","author":"Jiang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2026.101438_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: treatment of relapsing and metastatic prostate cancer","volume":"86","author":"Tilki","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.drup.2026.101438_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101227","article-title":"TGF\u03b2-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt\/\u03b2-catenin signaling pathway","volume":"81","author":"Ge","year":"2025","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101438_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101438_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","article-title":"Circular RNA in cancer","volume":"24","author":"Conn","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101438_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"Xu","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2026.101438_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-022-01345-w","article-title":"CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR","volume":"15","author":"Wang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101438_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12943-021-01476-7","article-title":"CircCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer","volume":"21","author":"Ling","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101438_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12943-022-01501-3","article-title":"CircFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF\/STAT3 axis","volume":"21","author":"Hu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101438_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41392-020-00359-5","article-title":"Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression","volume":"5","author":"Yang","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2026.101438_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc.2016.81","article-title":"Serine and one-carbon metabolism in cancer","volume":"16","author":"Yang","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101438_bib14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-020-2609-x","article-title":"Serine restriction alters sphingolipid diversity to constrain tumour growth","volume":"586","author":"Muthusamy","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101438_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature11743","article-title":"Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells","volume":"493","author":"Maddocks","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101438_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cmet.2023.12.013","article-title":"Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD","volume":"36","author":"Ghrayeb","year":"2024","journal-title":"Cell. Metab."},{"key":"10.1016\/j.drup.2026.101438_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-021-01480-x","article-title":"Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p","volume":"21","author":"Yu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101438_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41579-021-00621-9","article-title":"Mass spectrometry-based metabolomics in microbiome investigations","volume":"20","author":"Bauermeister","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drup.2026.101438_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancerstemcells: advances in knowledge and implications forcancertherapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2026.101438_bib20","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1200\/JCO.2007.15.1472","article-title":"Prostate cancer stem cells: a new target for therapy","volume":"26","author":"Maitland","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101438_bib21","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1158\/2159-8290.CD-23-0331","article-title":"Transposable elements are co-opted as oncogenic regulatory elements by lineage-specific transcription factors in prostate cancer","volume":"13","author":"Grillo","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2026.101438_bib22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.stem.2010.11.013","article-title":"Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation","volume":"7","author":"Lukacs","year":"2010","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.drup.2026.101438_bib23","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1038\/s41467-023-42571-1","article-title":"A circular RNA activated by TGF\u03b2 promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101438_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cell.2010.03.009","article-title":"Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP","volume":"141","author":"Hafner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101438_bib25","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1158\/0008-5472.CAN-20-1541","article-title":"Exogenous and endogenous sources of serine contribute to colon cancer metabolism, growth, and resistance to 5-fluorouracil","volume":"81","author":"Montrose","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101438_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade4113","article-title":"Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway","volume":"15","author":"Zhang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drup.2026.101438_bib27","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1158\/0008-5472.CAN-21-4074","article-title":"Metabolic and nonmetabolic functions of PSAT1 coordinate signaling cascades to confer EGFR inhibitor resistance and drive progression in lung adenocarcinoma","volume":"82","author":"Luo","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101438_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.113977","article-title":"Upregulation of serine metabolism enzyme PSAT1 predicts poor prognosis and promotes proliferation, metastasis and drug resistance of clear cell renal cell carcinoma","volume":"437","author":"Ye","year":"2024","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.drup.2026.101438_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41467-020-20223-y","article-title":"Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy","volume":"12","author":"Tajan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101438_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2014.07.006","article-title":"The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer","volume":"29","author":"Lederer","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2026.101438_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41586-020-2077-3","article-title":"A large-scale binding and functional map of human RNA-binding proteins","volume":"583","author":"Nostrand","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101438_bib32","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/s41590-019-0542-7","article-title":"Inducible degradation of lncRNA Sros1 promotes IFN-\u03b3-mediated activation of innate immune responses by stabilizing Stat1 mRNA","volume":"20","author":"Xu","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drup.2026.101438_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3892\/ijmm.2014.1629","article-title":"Regulation of mRNA transport, localization and translation in the nervous system of mammals (Review)","volume":"33","author":"Liegro","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.drup.2026.101438_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41392-020-0147-5","article-title":"Overexpression of PSAT1 regulated by G9A sustains cell proliferation in colorectal cancer","volume":"5","author":"Wang","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2026.101438_bib35","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2015.02.014","article-title":"The RNA binding protein quaking regulates formation of circRNAs","volume":"160","author":"Conn","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101438_bib36","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101438_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-020-01149-x","article-title":"Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1","volume":"19","author":"Hong","year":"2020","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.drup.2026.101438_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","article-title":"EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101438_bib39","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1038\/s41467-026-69556-0","article-title":"FOXJ1 mediates taxane resistance through regulation of microtubule dynamics","volume":"17","author":"Xie","year":"2026","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.drup.2026.101438_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-025-03272-3","article-title":"AGD1\/USP10\/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.drup.2026.101438_bib41","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.3390\/cancers15215273","article-title":"Therapeutic resistance models and treatment sequencing in advanced prostate cancer","volume":"15","author":"Schaaf","year":"2023","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.drup.2026.101438_bib42","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1158\/0008-5472.CAN-03-3111","article-title":"Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10)","volume":"64","author":"Hopper-Borge","year":"2004","journal-title":"Resist. docetaxel. Cancer Res."},{"issue":"12","key":"10.1016\/j.drup.2026.101438_bib43","article-title":"Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit","volume":"5","author":"Senatorov","year":"2024","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.drup.2026.101438_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100761","article-title":"Cross-resistance and drug sequence in prostate cancer","volume":"56","author":"Buck","year":"2021","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101438_bib45","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.7150\/thno.32796","article-title":"Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma","volume":"9","author":"Zhu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2026.101438_bib46","article-title":"Circ-MALAT1 functions as both an mRNA translation brake and a microRNA sponge to promote self-renewal of hepatocellular cancer stem cells","volume":"7","author":"Chen","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2026.101438_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13046-021-01896-9","article-title":"CircFAM73A promotes the cancer stem cell-like properties of gastric cancer through the miR-490-3p\/HMGA2 positive feedback loop and HNRNPK-mediated \u03b2-catenin stabilization","volume":"40","author":"Xia","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101438_bib48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.stem.2012.06.006","article-title":"Asymmetric segregation of the double-stranded RNA binding protein Staufen2 during mammalian neural stem cell divisions promotes lineage progression","volume":"11","author":"Kusek","year":"2012","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.drup.2026.101438_bib49","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1158\/0008-5472.CAN-16-1730","article-title":"Serine synthesis helps hypoxic cancer stem cells regulate redox","volume":"76","author":"Samanta","year":"2016","journal-title":"Cancer Res."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:32:46Z","timestamp":1785900766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"alternative-id":["S1368764626000890"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101438","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101438"}}